glp-1 and perimenopause Microdosing for Perimenopause: Benefits & Risks Weight Loss During Perimenopause: Rooted
Description
Any steroid taper must be done gradually under rheumatological supervision
Zeng D, Zeng Q, Li S, Lu J, Cheng N
For others, it becomes part of an ongoing maintenance approach
Other effects of these medications often lead to weight loss
This insight, combined with clinical gastric assessment, can support a more personalized conversation with your provider about GLP-1 feasibility
The mean changes from baseline to week 26 were -0.4 kg, -2.4 kg and -3.7 kg in the placebo, RYBELSUS 7 mg and RYBELSUS 14 mg arms, respectively
